A recently launched campaign starring patients and scientists shows Sanofi in hot pursuit of scientific innovation. | A ...

Sanofi’s stock narrative is shifting as analysts revise their consensus price target slightly downward, from $106.90 to $106.85. This minor adjustment reflects a careful reassessment of Sanofi’s ...

Sanofi is rolling out a new global campaign that features the stories of six real patients, to underscore its core purpose.

Sanofi's “Badge of Honor,” made with FCB Health New York, won gold for Data-Driven Campaign of the Year among suppliers, ...

The order is limited to Tenblock’s property and requests any new buildings be limited to 33 metres high, or about 10 storeys ...

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals ...

Sanofi successfully prices USD 3billion of bond issue Paris, France – October 28, 2025 - Sanofi announces that it has successfully priced its ...

Sanofi is narrowing development of one of its 5 billion euro ($5.4 billion), “pipeline-in-a-product” assets. The French drugmaker axed Sjögren’s syndrome from the list of targeted indications for ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organization (CDSCO), has approved ...

Sanofi’s ‘A Trusted Circle,’ made with Republica Havas Health, won bronze for Purpose-led Campaign of the Year among ...

Sanofi remporte cette année la palme du champion climatique du CAC40, selon une analyse réalisée par Les Ateliers du futur.

Sanofi Consumer Healthcare India Limited ( ($IN:SANOFICONR) ) just unveiled an update. Sanofi Consumer Healthcare India Limited announced the ...